FDA Alert: Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating DosingHome › News › FDA Alerts › Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing[09/06/2017- Drug Safety Communication - FDA]
